A study protocol to determine the effective dose of S-ketamine and others in preoperative sedation in children with congenital heart disease

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044551

Enrollment

Unknown

Registered

2021-03-24

Start date

2021-04-30

Completion date

Unknown

Last updated

2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

child's congenital heart disease

Interventions

SPO2 = 90% group:s-ketamine

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: The selection criteria of the children include: 1. 1 month to 72 months; 2. gender is not limited; 3. ASA classification I ~ III; 4. elective surgery for congenital heart disease.

Exclusion criteria

Exclusion criteria: The exclusion criteria are: 1. Allergic to the test drug; 2. severe liver and kidney dysfunction; 3. those with increased intracranial pressure; 4. other conditions not suitable for the test.

Design outcomes

Primary

Measure	Time frame
Ramsay;	—

Countries

China

Contacts

Public ContactHongbin Gu

1678 Dongfang Road, Pudong, Shanghai, China

floodgu@hotmail.com+86 18017721753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026